Abound Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Abound Financial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-327	Closed	-$7.01K	–	302
2026 Q1	$7.01K	Hold	327	–	–	﹤0.01%	223
2025 Q4	$3.05K	Buy	+327	New	+$2.73K	﹤0.01%	246
2025 Q2	–	Sell	-327	Closed	-$2.59K	–	113
2025 Q1	$2.59K	Buy	+327	New	+$3.52K	﹤0.01%	242

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Abound Financial's DAWN Position: Q2 2026 in Review

Abound Financial sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 327 shares — an estimated $7.01K sold.

Abound Financial first reported a position in DAWN in Q1 2025 and held it in 3 quarters. The position peaked at $7.01K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Abound Financial reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Abound Financial sold 327 Day One Biopharmaceuticals shares in Q2 2026, an estimated $7.01K.
Abound Financial first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 3 quarters.
Abound Financial's Day One Biopharmaceuticals position peaked at $7.01K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Abound Financial's 13F filing for Q2 2026, filed 14 Aug 2026.